CARTO® 3 EP Navigation System with Signal Processing Unit
Computer, Diagnostic, Programmable. 510(k) K200484, from Biosense Webster, Inc. (Irvin, CA). Product code DQK, class 2.
As of Nov 21, 2026, K200484 is an FDA 510(k) held by Biosense Webster, Inc., substantially equivalent on Nov 25, 2020 after 272 days, with no recalls tied to it in FDA's recall database.
- Review time: 272 days
- Recalls: 0
- Cited as a predicate by: 1 device
The intended use of the CARTO® 3 System is catheter-based cardiac electrophysiological (EP) procedures. The CARTO® 3 System provides information about the electrical activity of the heart and about catheter location during the procedure. The system can be used on patients who are eligible for a conventional electrophysiological procedure. The system has no special
- CARTO 3 EP Navigation System, Version 7.1 and AccessoriesK191660 · Biosense Webster, Inc. · Jul 20, 2019
- CARTO 3 EP Navigation System Version 7.2K213264 · Biosense Webster, Inc. · Oct 29, 2021
- Merge Hemo (Model RCSV2 (v11.3))K262171 · Merge Healthcare Incorporated · Nov 5, 2026
- Vivo (9002)K261886 · Catheter Precision, Inc. · Oct 30, 2026
- PulseAPI SmartWatchK254226 · PulseAI, Ltd. · Oct 27, 2026
- STAR Apollo™ Mapping SystemK263380 · Rhythm AI, Ltd. · Oct 23, 2026
- Intra-Operative Positioning System (IOPS) and IOPS Visionary SystemK263016 · Centerline Biomedical · Oct 1, 2026
- S-Patch CardioAIK254255 · Wellysis Corp. · Sep 25, 2026
- EnSite™ X EP SystemK261729 · Abbott Medical · Sep 17, 2026
- AVVIGO™+ Multi-Modality Guidance SystemK253692 · Boston Scientific · Aug 21, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 27, 2020
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1425
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files